Highlights
- Sales over the Year and quarter:
- Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 163.64 %. Marginal decrease of -80.28% in other income during this quarter.
- Profit over the Year and quarter: Significant improvement in profitability for Chemo Pharma Laboratories Ltd.,. Notable increase of 96.62 % in net profit Year to Year, Chemo Pharma Laboratories Ltd.,’s profitability dropped by -143.05 % Quarter to Quarter.
- EPS over the Year and quarter: EPS increased by 95.96 % Year to Year. EPS decreased by -143.02 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
| Expenses | Rs. 0.02 Cr | Rs. 0.02 Cr | Rs. 0.09 Cr | + 350 % | + 350 % |
| Operating Profit | Rs. -0.02 Cr | Rs. -0.02 Cr | Rs. -0.09 Cr | -350 % | -350 % |
| OPM % | 0 % | 0 % | 0 % | 0 % | 0 % |
| Other Income | Rs. -0.22 Cr | Rs. 0.71 Cr | Rs. 0.14 Cr | -80.28 % | + 163.64 % |
| Interest | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
| Depreciation | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
| Profit before tax | Rs. -0.24 Cr | Rs. 0.69 Cr | Rs. 0.05 Cr | -92.75 % | + 120.83 % |
| Tax % | -77.5 % | 0 % | 220.39 % | + 220.39 % | + 297.89 % |
| Net Profit | Rs. -0.15 Cr | Rs. 0.68 Cr | Rs. -0.29 Cr | -142.65 % | -93.33 % |
| EPS in Rs | Rs. -0.99 | Rs. 4.51 | Rs. -1.94 | -143.02 % | -95.96 % |
Today, we’re looking at Chemo Pharma Laboratories Ltd.,’s financial performance for the Q4(Mar 2024).Expenses ticked up slightly by 350 % quarter-on-quarter, aligning with the annual rise of 350 %. Operating profit, while down -350 % compared to last year, faced a quarter-on-quarter dip of -350 %, signaling a short-term contraction in margins.
Other income fell by -80.28 % compared to the last quarter, despite an annual growth of 163.64 %. Profit before tax grew annually by 120.83 % but saw a reduction from the preceding quarter by -92.75 %.
Tax expenses as a percentage of profits increased slightly by 297.89 % compared to last year, with a more notable quarter-on-quarter increase of 220.39 %. Net profit fell by -93.33 % year-on-year but witnessed a -142.65 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -95.96 % but a quarterly fall of -143.02 %. In summary, Chemo Pharma Laboratories Ltd.,’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
| Expenses | Rs. 0.02 Cr | Rs. 0.02 Cr | Rs. 0.09 Cr | + 350 % | + 350 % |
| Operating Profit | Rs. -0.02 Cr | Rs. -0.02 Cr | Rs. -0.09 Cr | -350 % | -350 % |
| Net Profit | Rs. -0.15 Cr | Rs. 0.68 Cr | Rs. -0.29 Cr | -142.65 % | -93.33 % |
| EPS in Rs | Rs. -0.99 | Rs. 4.51 | Rs. -1.94 | -143.02 % | -95.96 % |
In reviewing Chemo Pharma Laboratories Ltd.,’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Expenses rose by 350 % compared to the previous year, with a 350 % increase quarter-on-quarter. Operating Profit dropped by -350 % annually, and saw a -350 % decrease from the last quarter.
Net Profit showed yearly decrease of -93.33 %, and experienced a -142.65 % decrease from the previous quarter. Earnings Per Share (EPS) fell by -95.96 % annually, however dipped by -143.02 % compared to the last quarter. In essence, while Chemo Pharma Laboratories Ltd., faces strong annual decline indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.
